top of page



Breaking Barriers: Regulatory Hurdles in Approving mRNA-Based Therapeutics
The rapid development of mRNA-based therapeutics, catalyzed by the success of mRNA vaccines during the COVID-19 pandemic, has opened new...

Content Desk
2 min read
Â
Â
Â


Navigating New Frontiers: FDA's Approach to Pharmacovigilance in Gene and Cell Therapies
Gene and cell therapies continue to revolutionize the treatment landscape for various genetic and acquired diseases, as a consequence FDA...

Content Desk
2 min read
Â
Â
Â


Impact of Causality Analysis on Pharmacovigilance: Improving Drug Safety Outcomes
In the complex landscape of healthcare, ensuring the safety and efficacy of medicinal products is paramount. Central to this endeavor is...

Content Desk
3 min read
Â
Â
Â
bottom of page